JESSICA ZARSHENAS: Open Payments
NPI 1881458719 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,435 in 82 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $983 · 2025 $2,435
Food & beverage: $2,335Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $843 |
| Novartis Pharmaceuticals Corporation | 11 | $351 |
| Janssen Biotech, Inc. | 3 | $218 |
| E.R. Squibb & Sons, L.L.C. | 7 | $215 |
| Regeneron Healthcare Solutions, Inc. | 4 | $190 |
| LEO Pharma Inc. | 5 | $108 |
| GENZYME CORPORATION | 4 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
| UCB, Inc. | 4 | $77 |
| Amgen Inc. | 3 | $69 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Sotyktu, COSENTYX, BOTOX, Bimzelx, OTEZLA.
Industry payments across TN — which companies pay providers there.
